baber/WOPTO huggingface dataset:
Patent NZ-504101-A (NZ)
Title: A method of preparing a non-human mammal comprising reconstituting a non-human mammalian embryo
Inventor: CAMPBELL KEITH HENRY STOCKMAN
Filed: 1996-08-30
Abstract: A method of preparing a non-human mammal, comprising: a) i) reconstituting a non-human mammalian embryo by transferring a diploid nucleus from a donor cell into an unactivated, enucleated oocyte which is arrested in the metaphase of the second mitotic division without concomitantly activating the oocyte; ii) maintaining the reconstituted embryo without activation for a period of time sufficient for the embryo to become capable of developing to term; iii) activating the reconstituted embryo and iv) using a cell of the embryo of step (iii) as a donor cell and repeating steps (i) to (iii) to prepare a further embryo; b) transferring the embryo to a recipient non-human mammal and allowing an animal to develop to term from the embryo; and c) optionally, breeding from the non-human mammal so formed.
Patent NZ-504195-A (NZ)
Title: Gram-positive microorganism formate pathway
Inventor: MILLER BRIAN
IPC: C12N9/00
Filed: 1998-11-19
Abstract: A product can be produced from a gram positive microorganism by obtaining a microorganism capable of expressing the product and culturing the microorganism in the presence of formate and under conditions suitable for production of the product. The microorganism comprises either one or both of i) formate transport associated protein 1 (FTAP 1) and ii) formate transport associated protein 1(FTAP2). Preferably the microorganism is Bacillus and the product is a recombinant protein selected from a protease, lipase, amylase, pullanase, cellulase, glucose isomerase, laccase or a protein disulfide isomerase.
Patent NZ-507855-A (NZ)
Title: 24-Hydroxyvitamin D, analogs and uses for treating/prevention of hyperparathyroidism, hyperproliferative diseases, and immune and inflammatory responses
Inventor: BISHOP CHARLES W
IPC: A61K31/59
Filed: 1999-05-28
Abstract: Use of a 24-hydroxyvitamin D compound in treating or preventing bone loss or bone mineral content, and/or hyperparathyroidism, and/or hyperproliferation, or modulation of the immune and inflammatory responses. The 24-hydroxyvitamin D compound is represented by formula (I) or formula (III). With reference to formulae (I) and (III), Z represents a saturated or unsaturated, substituted or unsubstituted, straight-chain, branched or cyclic C4-C18 hydrocarbon group in which the C-24 is hydroxylated. Y is a methylene group if Y is double bonded to the A-ring or a methyl group or hydrogen if Y is single bonded. X is hydrogen, lower alkyl or lower fluoroalkyl.
Patent NZ-510474-A (NZ)
Title: Transformation and regeneration of genetically modified plants and plant materials from Eucalyptus and Pinus species
Inventor: FLINN BARRY
IPC: C12N15/09
Filed: 1999-09-15
Abstract: Methods are described for producing genetically modified plants, particularly woody plants, and most particularly plants of the Eucalyptus and Pinus species.  The methods involve transformation of target plant material with a desired genetic construct and regeneration of the transformed plant material using an adventitious shoot bud system.  The methods provide high transformation efficiency and reduce the duration of the transformation and regeneration protocols.  Stem segments of a target plant are transformed using Agrobacterium-mediated techniques, and adventitious shoot buds are regenerated from the Agrobacterium-infected stem segments.  Preferred culture media, including selection media, and improved plant culture techniques are disclosed.
Patent NZ-510481-A (NZ)
Title: Explosive composition comprising a discontinuous oxidiser phase dispersed throughout a continuous fuel phase
Inventor: MEDUSELAC MUAMER
IPC: C06B31/28
Filed: 1999-09-17
Abstract: Described is a water-in-oil emulsion explosive composition comprising an aqueous oxygen-supplying salt solution and anti-caking and stabilising agents as the discontinuous phase, and a continuous water-immiscible organic phase including an emulsifying agent, and an emulsifier selected from the group consisting of poly(isobutylene) succinic anhydride or poly(isobutylene) succinic acid, which has been derivatised with amine or alkanolamine.
Patent NZ-513052-A (NZ)
Title: Forehead support for facial mask
Inventor: HARRISON JONATHAN PAUL
IPC: A61M16/00
Filed: 2000-02-11
Abstract: A forehead support (10) is disclosed that is adapted to be  secured to a respiratory mask (16). The forehead support (10)  including  a joining member (14) for securing  to  the mask (16) and a cushion frame (12) pivotally mounted to  the joining  member (14). The cushion frame (12) is  adapted  to locate  one  or  more forehead cushions  (25).  The  cushion frame  (12) is also adapted to pivot relative to the joining member  (14).  The  cushion frame (12) is  also  selectively lockable  at  two  or more predetermined  angular  positions relative  to  the  joining member (14). A  respiratory  mask assembly  comprising a respiratory mask (16) and a  forehead support (10) adapted to be secured to the mask (16) is  also disclosed
Patent NZ-519360-A (NZ)
Title: Gaming machine with special symbols, where touching of symbol reveals the bonus prize won
Inventor: BENNETT NICHOLAS LUKE
IPC: A63F1/00
Filed: 2001-01-18
Abstract: A gaming machine (10) has a display (14) and a game controller (30) arranged to control images (18) on the display (14). The game controller (30) is arranged to play a game (16) wherein one or more random events are caused to be displayed on the display (14) and, if a predefined winning event or combination of events results, the machine (10) awards a prize. A predetermined symbol from a set of symbols of the game is selected as a bonus symbol. The display (14) is an interactive display means such that, when at least one of the bonus symbols appears then, by a player touching a part of the display (14) overlying the, or each, occurrence of the bonus symbol, a bonus prize is revealed in respect of the, or each, bonus symbol.
Patent NZ-524747-A (NZ)
Title: Methods and devices for delivering exogenously generated speech signals to enhance fluency in persons who stutter
Inventor: KALINOWSKI JOSEPH
IPC: G10L21/00
Filed: 2000-12-18
Abstract: A method for enhancing the fluency of persons who stutter that comprises: (a) Exogenously generating a speech signal of at least one prolonged voice gesture; (b) Producing speech defining a first speech signal corresponding to the patient speaking, the patient having a propensity to stutter during speech; and (c) Intermittently delivering the exogenously generated speech signal to the patient temporally proximate to the producing step such that the exogenously generated speech signal is audible to the patient and thereby enhancing the fluency of the patient.
Patent NZ-525091-A (NZ)
Title: Piperazinyl susbtituted piperidinyl compounds as antagonists of tachykinins
Inventor: ALVARO GIUSEPPE
IPC: A61P25/22
Filed: 2001-10-12
Abstract: Compounds of formula (I), wherein: R is halogen or alkyl, R1 is alkyl, R2 is H or alkyl, R3 is H or alkyl, R4 is trifluoromethyl, R5 is H, alkyl or C(O)R6, R6 is alkyl, cycloalkyl, NH-alkyl, or N-(alkyl)2, and n is from 1 to 3. The compounds are used in the manufacture of medicaments for the treatment of conditions mediated by tachykinins.
Patent NZ-534176-A (NZ)
Title: Aqueous herbicidal concentrate comprising a betaine type surfactant
Inventor: BRAMATI VALERIO
IPC: A01N57/20
Filed: 2003-01-28
Abstract: An aqueous phytopathological formulation is disclosed. It comprises: (a) a hydrosoluble salt of at least one aminophosphate or aminophosphonate type herbicide; (b) at least one principal surfactant selected from alkylbetaines and alkyl(amidoalkyl)-betaines; and (c) at least one additive selected from at least one of the following compounds: (i) amines or etheramines comprising at least one hydrocarbon radical containing 2 to 24 carbon atoms, optionally polyalkoxylated; (ii) acid or non acid phosphate mono- or di-esters, optionally polyalkoxylated; (iii) alkali metal, alkaline-earth metal, ammonium, alkylammonium, alkanolammonium, iron, zinc or manganese salts of a mineral acid and (iv) alkylmonoglycosides or alkylpolyglycosides.
Patent NZ-534339-A (NZ)
Title: Process for preparing scopine esters
Inventor: BRANDENBURG JOERG
IPC: C07D451/10
Filed: 2002-12-24
Abstract: A method for producing the scopine esters of general formula (1) is disclosed, wherein X ¯ and the groups R1 and Ar are as defined in the specification.
Patent NZ-534423-A (NZ)
Title: Modulation by multiple pulse per group keying and method of using the same
Inventor: HARTMANN CLINTON S
IPC: H04L25/49
Filed: 2002-12-26
Abstract: A system for producing a propagated signal is disclosed. The system includes an apparatus for encoding an element of data contained within a time period (100) of the propagated signal, where the time period (100) is divided into a group (110) of time slots (120). Multiple pulses (130) are distributed in a predetermined manner among the group (110) of time slots (120) by pulse group keying to encode the element of data.
Patent NZ-537093-A (NZ)
Title: Hydraulic cement based on calcium phosphate for surgical use
Inventor: BOHNER MARC
IPC: A61L27/00
Filed: 2003-05-13
Abstract: Hydraulic cement based on calcium phosphate for surgical use is disclosed, which comprises a first component comprising alpha-tricalcium phosphate (Ca3(PO4)2) powder particles, a second component comprising calcium sulphate dihydrate, and a third component comprising water, wherein the hydraulic cement does not contain more calcium sulfate hemihydrate (CSH) than 10 % of the total amount of said calcium sulphate dihydrate (CSD), and wherein it dose not contain a very basic component such as TTCP (tetracalcium phosphate Ca4(PO4)2O). This cement has the advantage that it consists of a limited amount of components, sets fast, and is easy to mix. This cement is suitable as a temporary bone replacement material.
Patent NZ-537625-A (NZ)
Title: Human orphan G protein-coupled receptors of nucleotide and peptide SEQ ID NOS: 13 and 14
Inventor: CHEN RUOPING
IPC: C12N/
Filed: 1999-10-13
Abstract: An isolated polynucleotide comprising a nucleotide sequence encoding the amino acid sequence of SEQ ID NO:14. Also disclosed are receptors of this sequence as well as those of SEQ ID NO:13, vectors containing the nucleotide sequences and non-human host cells which comprise the vectors.
Patent NZ-538163-A (NZ)
Title: Rhodococcus equi mutants and vaccines comprising same
Inventor: HONDALUS MARY
IPC: C12N1/20
Filed: 2003-07-14
Abstract: Disclosed is a mutant strain of Rhodococcus equi (R. equi), said mutant strain being a riboflavin auxotroph, and said mutant strain further having reduced pathogenicity relative to a wild type strain. The genetically stable mutant R. equi strain can be made by inserting a transposon into the gene that encodes DHBP synthase.
Patent NZ-541299-A (NZ)
Title: An improved user interface for displaying a gallery of formatting options applicable to a selected object
Inventor: BUTCHER AARON M
IPC: G06F3/048
Filed: 2005-07-18
Abstract: A user interface for providing a gallery of formatting options in an improved user interface comprises one or more tabs disposed in an upper row of the user interface. Each of the one or more tabs identifies a task that may be performed on a selected object and the one or more of the one or more tabs are operative upon selection to cause a display of a gallery of formatting controls. Each of one or more formatting controls contained in the gallery of formatting controls is associated with one or more formatting attributes that may be applied to the selected object; and each of the one or more formatting controls include a visual representation of the selected object illustrating how the selected object will be formatted if the formatting attributes associated with each of the one or more formatting controls are applied to the selected object.
Patent NZ-543295-A (NZ)
Title: DNA sequences for human angiogenesis genes
Inventor: GAMBLE JENNIFER RUTH
IPC: G01N33/566
Filed: 2002-09-19
Abstract: Disclosed is an isolated nucleic acid molecule which encodes a polypeptide that plays a role in an angiogenic process.
Patent NZ-543701-A (NZ)
Title: Programmable breastpump
Inventor: SILVER BRIAN H
IPC: A61M1/06
Filed: 2000-12-07
Abstract: A programmable breastpump for the expression of mother's milk having a mechanism for applying a cyclical pressure to the breast. A programmable controller has an interface for the inputting of programs to produce different shaped pressure/frequency sequences as required by factors such as breast condition, milk production, infant suckling action, etc.. A user may select from a plurality of programs depending on requirements.
Patent NZ-548313-A (NZ)
Title: A grapple
Inventor: CAMERON TERRANCE WILLIAM
Filed: 2006-07-05
Abstract: A tractor grapple includes a bottom jaw assembly 1 and the top jaw assembly 4 hinged together at A. The bottom jaw is shaped to be able to free-stand on a surface and presents a curving lower skeletal material engagement face 3 and a straight material engagement face above the lower portion that stands vertically when the jaw is free standing on a horizontal surface, and the top jaw assembly has a skeletal material engagement face 5 that curves in the opposite direction. The jaws both terminate at their respective distal ends with sets of fingers 14, 15, and when the jaws are fully closed the fingers of the top jaw extend back behind the distal finger region of the bottom jaw.
Patent NZ-550557-A (NZ)
Title: Bicyclic aromatic sulfinyl derivatives
Inventor: BACON EDWARD R
IPC: C07C317/44
Filed: 2005-04-13
Abstract: Disclosed are bicyclic aromatic sulfinyl derivatives of formula (I), wherein Ar is a bicyclic moiety and Y is an alkylene moiety, wherein the other substituents are disclosed within the specification. Pharmaceutical compositions comprising the above mentioned compound of formula (I) are also disclosed. Also disclosed is the use of the above mentioned compound in the manufacture of a medicament for treating excessive sleepiness associated with narcolepsy, obstructive sleep apnoea or shift work disorder; Parkinson's disease; Alzheimer's disease; attention deficit disorder; attention deficit hyperactivity disorder; depression; or fatigue.
Patent NZ-552404-A (NZ)
Title: Compounds, compositions and methods
Inventor: MORGAN BRADLEY P
IPC: A61K31/40
Filed: 2005-06-16
Abstract: The disclosure relates to the compound methyl 4-[(2-fluoro-3-{[(6-methyl(3-pyridyl))amino]carbonylamino}-phenyl)methyl]piperazinecarboxylate or a pharmaceutically acceptable salt thereof. Also disclosed is a composition comprising this compound and the use of this compound in the manufacture of a medicament to treat heart failure.
Patent NZ-554458-A (NZ)
Title: Method of formation of the shape-retentive aggregates of gel particles and their uses
Inventor: MORO DANIEL G
IPC: A61L27/54
Filed: 2005-10-06
Abstract: Disclosed is a suspension system for forming a shape-retentive aggregate of gel particles, comprising: a plurality of gel particles dispersed in a polar liquid or a mixture of two or more polar liquid(s), wherein the polar liquid or at least one of the two or more polar liquids comprise(s) one or more hydroxyl groups and; wherein the gel particles have an average diameter of less than 955 nanometers and a first absolute zeta potential; and, wherein the plurality of gel particles are formed from the suspension polymerization of a monomer or two or monomers, wherein the monomer(s) are selected from the group consisting of a 2-alkenoic acid, a hydroxy(2C - 4C)alkyl 2-alkenoate, a hydroxy(2C - 4C)alkoxy(2C - 4C)alkyl 2-alkenoate, a (1 C - 4C)alkoxy(2C 4C)alkoxy(2C - 4C)alkyl 2-alkenoate and a vicinyl epoxy(1C - 4C)alkyl 2-alkenoate and a combination of two or more thereof in the presence of from 0.01 to 10 mol percent of a surfactant; and wherein the suspension system is suitable to be introduced at a selected introduction rate into a receiving medium wherein the gel particles acquire a second absolute zeta potential which is lower (closer to zero) than the first absolute zeta potential whereupon the gel particles coalesce into a shape-retentive aggregate held together by non-covalent bond physical forces comprising hydrophobic-hydrophilic interactions and hydrogen bonds. The disclosure also relates to the application of the shape-retentive aggregates in orthopedic applications such as tissue scaffolding, cartilage and bone repair, meniscus repair/replacement, artificial spinal discs, artificial tendons and ligaments, and bone defect filler.
Patent NZ-566767-A (NZ)
Title: Intubating system where in an identifiable additive is introduced and measured to determine leak
Inventor: EFRATI SHAI
IPC: A61M16/04
Filed: 2006-08-21
Abstract: A system for performing endotracheal intubation is disclosed. The system comprises an endotracheal tube associated with a cuff, an additive delivering unit configured to deliver at least one identifiable additive through the endotracheal tube, and a measuring device for measuring a level of delivered identifiable additive. The use of identifiable additive in the system allows monitoring the level of additive and comparing it with an optimum level and then adjusting the inflation of the cuff accordingly.
Patent NZ-567243-A (NZ)
Title: N-(Hetero) aryl indole derivatives as pesticides
Inventor: FRUCHTEL JORG
IPC: A01N43/38
Filed: 2006-11-02
Abstract: Disclosed herein Is a N-(hetero) aryl indole of general formula (Ia) wherein the substituents are as defined in the specification, pharmaceutical compositions comprising said compounds, and methods for their preparation. Said compounds are useful in controlling parasites on warm-blooded animals excluding humans, as well as the control of parasites on plants.
Patent NZ-574375-A (NZ)
Title: 2-(5-fluoro-2-methyI-3-(2-(phenylsulfonyl)benzyl)-1H-indol-1-yl) acetic acid derivatives having CRTH2 antagonist activity
Inventor: ARMER RICHARD EDWARD
IPC: A61K31/405
Filed: 2007-07-20
Abstract: Disclosed are compounds of general formulae (I) and (II) wherein R is phenyl optionally substituted with one or more halo substituents, and R1 is as defined in the specification; their pharmaceutically acceptable salts, hydrates, solvates, complexes or prodrugs, and processes for their preparation. The compounds are useful in orally administrable compositions for the treatment of allergic diseases such as asthma, allergic rhinitis and atopic dermatitis.
Patent NZ-575218-A (NZ)
Title: Use of the enantiomer (1S,2R) of milnacipran for the preparation of a medicament
Inventor: DEREGNAUCOURT JEAN
IPC: A61K31/135
Filed: 2004-02-16
Abstract: Disclosed is the use of a mixture of the enantiomers of milnacipran (Z(±)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide), as well as their pharmaceutically acceptable salts, such mixture being enriched in the (1S,2R) enantiomer such that the mass/mass ratio of the (1S,2R) enantiomer to the (1R,2S) enantiomer is greater than or equal to 55:45, for the preparation of a medicament for the treatment or prevention of conditions or disorders by double inhibition of serotonin (5-HT) and noradrenaline (NA) reuptake. The mixture limits the risks of cardiovascular disturbances related to the administration of milnacipran in its racemic mixture form. (62) Divided Out of 541733
Patent NZ-578314-A (NZ)
Title: Tube for enteral nutrition
Inventor: WOLKENSTORFER REINHOLD
IPC: A61J15/00
Filed: 2007-12-05
Abstract: Disclosed is a tube for percutaneous endoscopic gastrostomy, said tube having at least on or in surface regions of the tube an antiseptically or antimicrobially acting compound that releases metal ions or colloidal metal wherein said compound is in the form of nanoparticles.
Patent NZ-581538-A (NZ)
Title: Authentication of security documents by analysis of features characteristic to printing methods
Inventor: LOHWEG VOLKER
IPC: G07D7/20
Filed: 2008-06-02
Abstract: Disclosed is a method for checking the authenticity of security documents using characteristic visual features intrinsic to the processes used for producing the security documents. Authentic security documents comprise security features printed, applied or otherwise provided on the security documents. The authentication method is performed by acquiring a sample image of at least one region of interest of the surface of a candidate document to be authorised. The region of interest is selected to encompass at least part of the security features. The sample image is then digitally processed by performing a decomposition of the image into at least one scale sub-space containing high resolution details of the sample image. Classifying features are then extracted from the scale sub-space. These extracted classifying features are used to derive an authenticity rating of the candidate document.
Patent NZ-581766-A (NZ)
Title: Resistance to abiotic stress in plants involving an rks (receptor kinase-like serk) gene
Inventor: BORDIER ADELINE AMANDINE COLETTE
IPC: C12N15/82
Filed: 2008-06-04
Abstract: Disclosed is a method to confer abiotic stress tolerance to a plant by providing said plant with a nucleotide sequence encoding an RKS gene or a homologue having at least 70% sequence identity thereto.
Patent NZ-587909-A (NZ)
Title: Process of making a compressed tablets containing valsartan and microcrystalline cellulose
Inventor: BULLOCK GILLIAN ROSEMARY
IPC: C07D257/04
Filed: 1999-12-22
Abstract: Disclosed is a process of making a compressed tablet having 20 to 360 mg of valsartan in free form as the only active agent, which amounts to 20 to 65% by weight of valsartan; 31 to 65% by weight of microcrystalline cellulose; and optionally crospovidone (wherein the weight ratio of microcrystalline cellulose to crospovidone is from 7:1 to 1:1); based on the total weight of the core components of said compressed tablet, wherein said process comprises the steps of i) grinding the active agent and pharmaceutically acceptable additives; ii) subjecting a mixture of the ground active agent and additives to compression to form a comprimate; iii) converting the comprimate to form a granulate; and iv) compressing the granulate to form the compressed tablet.
Patent NZ-590619-A (NZ)
Title: High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein
Inventor: RETALLACK DIANE
IPC: G01N33/50
Filed: 2009-07-01
Abstract: Disclosed is an in vitro method for high-throughput screening to simultaneously identity a fused binding region that binds a selected target, and an expression plasmid or host cell therefor, the method comprising: fusing a nucleic acid sequence encoding a binding region that interacts with the selected target, in frame with each of a plurality of nucleic acids, each of the plurality of nucleic acids encoding a different molecule, wherein each molecule is selected from the group of molecules consisting of a scaffold of antibody constant regions and, another binding region, to make fused binding regions; cloning each of the fused binding regions into each of a plurality of plasmids, each said plasmid comprising at least one expression signal selected from the group consisting of a transcription signal, a translation signal, and a protein secretion signal; transforming a bacterial host cell with the cloned fused binding domain plasmids; simultaneously expressing the fused binding domains in the bacterial host cell transformants in a high throughput manner; and screening expressed fused binding regions for antigen-binding activity, wherein the screening for antigen-binding activity allows identification of a fused binding regions that binds the selected target, and identification of the expression plasmid or host cell therefor, wherein the bacterial host cell has one or more protease genes deleted or overexpresses one or more folding modulator.